Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 2/2011

01.04.2011

Ocular and Orbital Pain for the Headache Specialist

verfasst von: Alexander L. Ringeisen, Andrew R. Harrison, Michael S. Lee

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Ocular pain is most commonly associated with redness and inflammation; however, eye pain can also occur in the absence of grossly visible pathology. Pain in the quiet eye can be the first sign of a number of threatening conditions. Many of these conditions such as intermittent angle closure glaucoma, carotid artery dissection, idiopathic intracranial hypertension, and giant cell arteritis can lead to permanent vision loss or blindness. In this review, ocular history and examination techniques are summarized. The article also reviews pertinent ocular, orbital, referred, and other causes of eye pain in the quiet eye. The neurologist and headache specialist should recognize when consultation with an ophthalmologist is necessary.
Literatur
1.
Zurück zum Zitat Harooni H, Golnik KC, Geddie B, et al.: Diagnostic yield for neuroimaging in patients with unilateral eye or facial pain. Can J Ophthalmol 2005, 40(6):759–63.PubMed Harooni H, Golnik KC, Geddie B, et al.: Diagnostic yield for neuroimaging in patients with unilateral eye or facial pain. Can J Ophthalmol 2005, 40(6):759–63.PubMed
2.
3.
Zurück zum Zitat Schindler KS, Sankar PS, Volpe NJ, et al.: Intermittent headaches as the presenting sign of subacute angle closure glaucoma. Neurology 2005, 65:757–8.CrossRef Schindler KS, Sankar PS, Volpe NJ, et al.: Intermittent headaches as the presenting sign of subacute angle closure glaucoma. Neurology 2005, 65:757–8.CrossRef
4.
Zurück zum Zitat Galor A, Thorne JE: Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33:835–54.PubMedCrossRef Galor A, Thorne JE: Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33:835–54.PubMedCrossRef
5.
Zurück zum Zitat Paraja JA, Sanchez-del-Rio M: Primary trochlear headache and other trochlear painful disorders. Curr Pain Headache Rep. 2006;10:316–20.CrossRef Paraja JA, Sanchez-del-Rio M: Primary trochlear headache and other trochlear painful disorders. Curr Pain Headache Rep. 2006;10:316–20.CrossRef
6.
Zurück zum Zitat Yanguela J, Sanchez-del-Rio M, Bueno A, et al.: Primary trochlear headache; a new cephalgia generated and modulated in the trochlear region. Neurology 2004, 62:1134–40.PubMed Yanguela J, Sanchez-del-Rio M, Bueno A, et al.: Primary trochlear headache; a new cephalgia generated and modulated in the trochlear region. Neurology 2004, 62:1134–40.PubMed
7.
Zurück zum Zitat • Mughal M, Longmuir R: Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep 2009, 9:384–9. Traditionally, testing for Horner syndrome is done using 10% cocaine. This is a difficult drug to obtain and store for physicians because of its classification as a controlled substance. The authors conclude that apraclonidine is a new and dependable diagnostic test for Horner syndrome; however, they do raise concern about the number of false-negative tests and the safety of apraclonidine testing in children. PubMedCrossRef • Mughal M, Longmuir R: Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep 2009, 9:384–9. Traditionally, testing for Horner syndrome is done using 10% cocaine. This is a difficult drug to obtain and store for physicians because of its classification as a controlled substance. The authors conclude that apraclonidine is a new and dependable diagnostic test for Horner syndrome; however, they do raise concern about the number of false-negative tests and the safety of apraclonidine testing in children. PubMedCrossRef
8.
Zurück zum Zitat Bartsch T, Goadsby PJ: Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002, 125(7):1496–1509.PubMedCrossRef Bartsch T, Goadsby PJ: Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002, 125(7):1496–1509.PubMedCrossRef
9.
Zurück zum Zitat Evers S: Status on the use of botulinum toxin for headache disorders. Curr opin neurol 2006, 19:310–15.PubMed Evers S: Status on the use of botulinum toxin for headache disorders. Curr opin neurol 2006, 19:310–15.PubMed
10.
Zurück zum Zitat Obermann M, Katsarava Z: Update on trigeminal neuralgia. Expert Rev Neurother. 2009, 9:323–9.PubMedCrossRef Obermann M, Katsarava Z: Update on trigeminal neuralgia. Expert Rev Neurother. 2009, 9:323–9.PubMedCrossRef
11.
Zurück zum Zitat Cheng TM, Cascino TL, Onofrio BM: Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 1993, 43(11):298–302. Cheng TM, Cascino TL, Onofrio BM: Comprehensive study of diagnosis and treatment of trigeminal neuralgia secondary to tumors. Neurology 1993, 43(11):298–302.
12.
Zurück zum Zitat Gronseth G, Crucus G, Alksne J, et al.: Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the quality standards subcommittee of the american academy of Neurology and the European federation of neurological societies. Neurology 2008, 71:1183–90PubMedCrossRef Gronseth G, Crucus G, Alksne J, et al.: Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the quality standards subcommittee of the american academy of Neurology and the European federation of neurological societies. Neurology 2008, 71:1183–90PubMedCrossRef
13.
14.
Zurück zum Zitat Sjaastad O, Stolt-Nielsen A, Pareja JA, et al.: Supraorbital neuralgia. The clinical manifestations and a possible therapeutic approach. Headache 1999, 39:204–12.PubMedCrossRef Sjaastad O, Stolt-Nielsen A, Pareja JA, et al.: Supraorbital neuralgia. The clinical manifestations and a possible therapeutic approach. Headache 1999, 39:204–12.PubMedCrossRef
16.
Zurück zum Zitat Williams MH, Broadley SA: SUNCT and SUNA: Clinical features and medical treatment. Journal of Clinical Neuroscience 2008, 15:526–34.PubMedCrossRef Williams MH, Broadley SA: SUNCT and SUNA: Clinical features and medical treatment. Journal of Clinical Neuroscience 2008, 15:526–34.PubMedCrossRef
17.
Zurück zum Zitat Matharu M, Goadsby P: Cluster headache—update on a common neurological problem. Pract Neurol 2001, 1: 42–9.CrossRef Matharu M, Goadsby P: Cluster headache—update on a common neurological problem. Pract Neurol 2001, 1: 42–9.CrossRef
18.
Zurück zum Zitat Cittadini E, Matharu MS, Goadsby PJ: Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain 2008, 131:1142–55.PubMedCrossRef Cittadini E, Matharu MS, Goadsby PJ: Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain 2008, 131:1142–55.PubMedCrossRef
19.
Zurück zum Zitat Matharu MS, Boes CJ, Goadsby PJ: Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 2003, 63:1637–77.PubMedCrossRef Matharu MS, Boes CJ, Goadsby PJ: Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 2003, 63:1637–77.PubMedCrossRef
20.
Zurück zum Zitat Goadsby PJ, Cohen AS, Matharu MS: Trigeminal autonomic cephalgias: diagnosis and treatment. Curr Neurol Neursci Rep 2007, 7:117–25.CrossRef Goadsby PJ, Cohen AS, Matharu MS: Trigeminal autonomic cephalgias: diagnosis and treatment. Curr Neurol Neursci Rep 2007, 7:117–25.CrossRef
21.
Zurück zum Zitat Favier I, van Vliet JA, Roon KI et al.: Trigeminal autonomic cephalgias dues to structural lesions: a review of 31 cases. Arch Neurol 2007, 64:25–31.PubMedCrossRef Favier I, van Vliet JA, Roon KI et al.: Trigeminal autonomic cephalgias dues to structural lesions: a review of 31 cases. Arch Neurol 2007, 64:25–31.PubMedCrossRef
Metadaten
Titel
Ocular and Orbital Pain for the Headache Specialist
verfasst von
Alexander L. Ringeisen
Andrew R. Harrison
Michael S. Lee
Publikationsdatum
01.04.2011
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 2/2011
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-010-0167-6

Weitere Artikel der Ausgabe 2/2011

Current Neurology and Neuroscience Reports 2/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.